jRCT2062260015招募中不适用
Exploratory, Single-arm, Single-center, Investigator-initiated Clinical Trial to Evaluate Safety and Efficacy of Subretinal Implantation of OUH-MU001 Using OUH-MU Injector in Patients with Retinitis Pigmentosa (OUReP001)
未提供0 个研究点目标入组 3 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- No limit 至 No limit(—)
- 性别
- All
入选标准
- •The patient has been diagnosed with retinitis pigmentosa.
- •There is no corneal opacity in the eye, and the visual acuity is light perception.
- •The visual acuity of the fellow eye is diagnosed as light perception, hand movement or counting fingers.
- •The retinal imaging of the eye by optical coherence tomography (OCT) demonstrates preservation of two retinal layers, namely the nerve fiber layer and the inner plexiform layer.
- •Cataract surgery in the study eye was performed at least two weeks prior to the screening.
- •The patient has cognitive capacity.
- •Written informed consent to participate in this clinical trial has been obtained.
- •It has been determined that the observations and examinations specified in the protocol can be performed.
排除标准
- •The study eye has other ocular diseases except for retinitis pigmentosa.
- •(1) Glaucoma
- •(2) Optic nerve atrophy
- •(3) Corneal opacity
- •(4) Acute ocular infection
- •There is a history of retinal detachment surgery in the study eye, except for laser treatment for retinal tears.
- •The fundus cannot be visualized due to cataract in the study eye.
- •Cataract surgery was performed within two weeks prior to the start of screening.
- •The investigator judges that there is a history of drug allergy.
- •ECOG Performance Status is 3 or higher.
- •The patient has serious comorbidities such as hepatic, renal, cardiac, pulmonary, hematologic, metabolic, or psychiatric disorders.
- •The patient is pregnant, breastfeeding, possibly pregnant, intends to become pregnant during the study period, or cannot agree to contraception during the study period.
- •The patient is participating in another clinical trial or interventional clinical study, or less than three months have passed since completion of follow-up for such a trial or study.
- •The investigator judges the patient to be unsuitable for enrollment from social or ethical perspectives.
研究者
相似试验
尚未招募
4 期
Use of Cariprazine drug in Indian patients having Major Depressive DisorderCTRI/2024/01/062163Not Applicable100
已完成
Unknown
Effectiveness Of Biomin Containing Toothpaste In The Management of Dental HypersensitivityCTRI/2024/06/068300Dr Amit Mishra120
尚未招募
不适用
A phase II study of Ad-SGE-REIC-NS in patients with recurrent glioblastomarecurrent glioblastomajRCT206325010527
尚未招募
不适用
CGUARDIANS III IDE Pivotal TrialCarotid Artery StenosisNCT07277296InspireMD103
尚未招募
Unknown
To Evaluate the Safety and Performance of Mural Drug Eluting Stent .CTRI/2025/12/099358Meril Life Sciences Pvt. Ltd136
